Studies using a mouse model of chronic pancreatitis and fibrosis revealed that CD39 deficiency led to a marked reduction in fibrosis and elevated levels of antifibrotic IFN-γ[38], suggesting a role for CD39 in promoting pancreatic tissue fibrosis.[37]. This evidence concerns the gene ENTPD1 and chronic pancreatitis.